|

TGRX-678 Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Shenzhen TargetRx Co., Ltd.2

Indications

  • Cancer2
  • Accelerated Phase CML1
  • Chronic Myelogenous Leukemia1
  • Chronic Myeloid Leukemia1

Other1 trial

TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients
Phase 2

Houston, Texas1 trial

TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia

The University of Texas MD Anderson Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.